Key Financial Figures

Financial Performance (₹ in Lakhs):

  • Total Income: ₹9819.84 (FY26) vs ₹6834.71 (FY25) - 44% increase
  • Sales (Net): ₹9595.46 (FY26) vs ₹6650.83 (FY25)
  • Other Income: ₹224.38 (FY26) vs ₹183.88 (FY25)
  • Profit before Tax: ₹1519.39 (FY26) vs ₹1246.71 (FY25)
  • Net Profit after Tax: ₹1081.38 (FY26) vs ₹927.33 (FY25) - 17% increase
  • Equity Share Capital: ₹575.73 (unchanged from FY25)
  • Other Equity: ₹7125.66 (FY26) vs ₹6300.44 (FY25)
  • Net Worth: ₹7701.39 (FY26) vs ₹6876.17 (FY25)

Dividend Declaration:

  • Recommended dividend of ₹5 per equity share (50%) for FY26
  • Total cash outflow: ₹287.86 lakhs if approved
  • Previous year: ₹4.50 per share (45%)
  • Record date: 7th August 2026
  • Payment within 30 days of AGM approval

Ten-Year Financial Highlights:

Shows consistent growth trajectory from FY17 to FY26:

  • Total Income grew from ₹4587.61L (FY17) to ₹9819.84L (FY26)
  • Net Profit increased from ₹333.66L (FY17) to ₹1081.38L (FY26)
  • EPS increased from ₹5.80 (FY17) to ₹18.78 (FY26)
  • Dividend payout increased from 20% (FY17) to 50% (FY26)

AGM Details

  • 36th Annual General Meeting: 14th August 2026 at 3:00 PM
  • Mode: Video Conferencing/Other Audio Visual Means
  • Business to be transacted:
  • Adoption of audited financial statements
  • Declaration of dividend
  • Re-appointment of Ms. Karthika Nair (DIN 00019695) who retires by rotation
  • Ratification of Cost Auditor remuneration of ₹75,000 + taxes for FY27

Corporate Governance

Board Composition:

  • Chairperson & Managing Director: Ms. Jayashree Nair
  • Managing Director & CFO: Mr. S. C. Kachhara
  • Non-Executive Director: Ms. Karthika Nair
  • Independent Directors: Mr. Prabhakar Dalal, Dr. Mitul Patel, Mr. Suresh Chandra Kookada
  • Company Secretary: Ms. Nikita Phatak

Board Meetings:

  • 4 meetings held during FY25-26 (100% attendance by all directors)
  • All independent directors confirmed compliance with independence criteria

Committees:

  • Audit Committee: Mr. Suresh Chandra Kookada (Chairman), Mr. Prabhakar Dalal, Mr. S. C. Kachhara
  • Nomination & Remuneration Committee: Mr. Prabhakar Dalal (Chairman), Dr. Mitul Patel, Mr. Suresh Chandra Kookada
  • Stakeholders Relationship Committee: Ms. Karthika Nair (Chairperson), Ms. Jayashree Nair, Mr. S. C. Kachhara, Dr. Mitul Patel
  • CSR Committee: Ms. Jayashree Nair (Chairperson), Mr. S. C. Kachhara, Ms. Karthika Nair, Mr. Suresh Chandra Kookada
  • Risk Management Committee: Ms. Jayashree Nair (Chairperson), Mr. S. C. Kachhara, Ms. Karthika Nair

Operational Highlights

Business Segments:

1. Pharmaceuticals Manufacturing: Therapeutic formulations covering wide range

2. Renewable Energy: 2 wind turbine generators (0.8MW each) at Jaisalmer, Rajasthan

Wind Power Generation:

  • FY26: Generated 18,01,980 kWh with revenue of ₹86.15L
  • FY25: Generated 18,52,250 kWh with revenue of ₹103.86L

R&D Activities:

  • R&D Centre at Mumbai approved by DSIR, Ministry of Science & Technology
  • R&D expenditure: ₹60.15L (0.61% of total revenue)
  • Focus on complex drug delivery systems and process improvement

CSR Activities

  • CSR Obligation: ₹24.52L (2% of average net profit)
  • Actual Spending: ₹24.54L on education and skill development
  • Key Projects: Educational assistance, R&D sponsorship, vocational training for differently-abled

Auditors:

  • Statutory Auditors: M/s. CLB & Associates, Chartered Accountants (till 37th AGM)
  • Secretarial Auditors: M/s JHR & Associates, Company Secretaries (till 31st March 2030)
  • Cost Auditors: M/s. Krishna S & Associates, Cost Accountants (for FY27)

Compliance Status:

  • No material orders passed by regulators/courts
  • No significant related party transactions
  • All statutory dues regularly paid
  • No fraud reported during the year

Shareholding Pattern

  • Promoters, Directors & Relatives: 49.70%
  • Companies/Bodies Corporate: 7.68%
  • General Public: 41.21%
  • NRI's: 1.41%
  • Dematerialized Shares: 98.69% of total equity shares

Voting Arrangements

  • Remote e-voting period: 11th August 2026 (9 AM) to 13th August 2026 (5 PM)
  • Scrutinizer: Mr. Ankit Varia of M/s Ankit Varia & Co., Chartered Accountant
  • Results declaration: Within 48 hours of AGM conclusion

IEPF Transfers

  • Transferred unclaimed dividend of ₹10,51,450 and 3015 shares for FY 2017-18 to IEPF
  • Upcoming transfers scheduled for subsequent years as per prescribed timelines

Other Significant Information

  • Bankers: Central Bank of India
  • Registrars & Transfer Agent: MUFG Intime India Private Limited
  • Credit Rating: CRISIL BBB-/Stable and A3 for bank facilities
  • Employee Strength: 95 employees
  • Whistleblower Complaints: None during FY26
  • Sexual Harassment Complaints: None during FY26

Forward-looking Statements

The Management Discussion & Analysis contains forward-looking statements based on current expectations and assumptions. Actual results may differ due to external factors including geopolitical tensions, supply chain disruptions, and regulatory changes.